Eosinophilic count as a biomarker for prognosis of melanoma patients and its importance in the response to immunotherapy

JOURNAL ARTICLE published February 2017 in Immunotherapy

Authors: Alvaro Moreira | Waltraud Leisgang | Gerold Schuler | Lucie Heinzerling